
HBR On Strategy
The Key to Preserving a Long-Term Competitive Advantage
Mar 27, 2024
Howard Yu, Lego Professor of Management and Innovation, discusses the enduring competitive advantage of pharmaceutical companies in Basel, Switzerland. He highlights the evolution from chemical dyes to microbiology, emphasizing the importance of repackaging knowledge for innovation. The episode explores the key elements of strategy, innovation, and long-term competitiveness in the pharmaceutical industry.
25:56
Episode guests
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Transitioning from chemical dyes to microbiology led Basel pharma companies to innovation and longevity.
- Rethinking existing knowledge to pioneer new products and services is crucial for enduring competitive advantage.
Deep dives
Historic Companies' Transition and Longevity
Historic pharma companies in Basel transitioned from chemical dye makers to microbiology, ensuring enduring businesses. This shift from organic chemistry to microbiology led to ongoing innovation and longevity. The companies rethought their knowledge to pioneer new products, emphasizing persistence and long-term experimentation for innovation.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.